Induction of a step in carcinogenesis that is normally associated with mutagenesis by nonmutagenic concentrations of 5-azacytidine (original) (raw)
Abstract
The permanent cell line BHK-21/cl 13 can be transformed by mutagenic carcinogens as the result of the induction of a recessive somatic mutation. Yet when these cells were treated with 5-azacytidine under conditions in which no mutants resistant to either ouabain or 6-thioguanine could be detected, they were transformed efficiently. These transformants were induced, not selected. 6-Azacytidine was ineffective at transforming BHK cells; 2'-deoxy-5-azacytidine was exceptionally effective. When tested by cell fusion, transformants induced by 5-azacytidine fell into the same complementation group as those induced by highly mutagenic carcinogens, but they were phenotypically distinct in that they were unstable during prolonged passage and rarely displayed the temperature-limited phenotypes so common among BHK transformants induced by strongly mutagenic carcinogens. These results raise the possibility that a cell can be induced by either genetic or epigenetic means to traverse the same single step in carcinogenesis.
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Ashman C. R., Davidson R. L. Bromodeoxyuridine mutagenesis in mammalian cells is related to deoxyribonucleotide pool imbalance. Mol Cell Biol. 1981 Mar;1(3):254–260. doi: 10.1128/mcb.1.3.254. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Benedict W. F., Banerjee A., Gardner A., Jones P. A. Induction of morphological transformation in mouse C3H/10T1/2 clone 8 cells and chromosomal damage in hamster A(T1)C1-3 cells by cancer chemotherapeutic agents. Cancer Res. 1977 Jul;37(7 Pt 1):2202–2208. [PubMed] [Google Scholar]
- Bishop J. M. Cellular oncogenes and retroviruses. Annu Rev Biochem. 1983;52:301–354. doi: 10.1146/annurev.bi.52.070183.001505. [DOI] [PubMed] [Google Scholar]
- Bodner A. J., Ting R. C., Gallo R. C. Induction of differentiation of human promyelocytic leukemia cells (HL-60) by nucleosides and methotrexate. J Natl Cancer Inst. 1981 Nov;67(5):1025–1030. [PubMed] [Google Scholar]
- Bouck N., di Mayorca G. Chemical carcinogens transform BHK cells by inducing a recessive mutation. Mol Cell Biol. 1982 Feb;2(2):97–105. doi: 10.1128/mcb.2.2.97. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Bouck N., di Mayorca G. Somatic mutation as the basis for malignant transformation of BHK cells by chemical carcinogens. Nature. 1976 Dec 23;264(5588):722–727. doi: 10.1038/264722a0. [DOI] [PubMed] [Google Scholar]
- Cavenee W. K., Dryja T. P., Phillips R. A., Benedict W. F., Godbout R., Gallie B. L., Murphree A. L., Strong L. C., White R. L. Expression of recessive alleles by chromosomal mechanisms in retinoblastoma. 1983 Oct 27-Nov 2Nature. 305(5937):779–784. doi: 10.1038/305779a0. [DOI] [PubMed] [Google Scholar]
- Clough D. W., Kunkel L. M., Davidson R. L. 5-Azacytidine-induced reactivation of a herpes simplex thymidine kinase gene. Science. 1982 Apr 2;216(4541):70–73. doi: 10.1126/science.6175023. [DOI] [PubMed] [Google Scholar]
- Constantinides P. G., Taylor S. M., Jones P. A. Phenotypic conversion of cultured mouse embryo cells by aza pyrimidine nucleosides. Dev Biol. 1978 Sep;66(1):57–71. doi: 10.1016/0012-1606(78)90273-7. [DOI] [PubMed] [Google Scholar]
- Cooper D. N. Eukaryotic DNA methylation. Hum Genet. 1983;64(4):315–333. doi: 10.1007/BF00292363. [DOI] [PubMed] [Google Scholar]
- Davidson R. L., Kaufman E. R. Deoxycytidine reverses the suppression of pigmentation caused by 5-BrdUrd without changing the amount of 5-BrdUrd in DNA. Cell. 1977 Dec;12(4):923–929. doi: 10.1016/0092-8674(77)90156-8. [DOI] [PubMed] [Google Scholar]
- Doerfler W. DNA methylation and gene activity. Annu Rev Biochem. 1983;52:93–124. doi: 10.1146/annurev.bi.52.070183.000521. [DOI] [PubMed] [Google Scholar]
- FARBER E. ETHIONINE CARCINOGENESIS. Adv Cancer Res. 1963;7:383–474. doi: 10.1016/s0065-230x(08)60986-0. [DOI] [PubMed] [Google Scholar]
- Fernandez A., Mondal S., Heidelberger C. Probabilistic view of the transformation of cultured C3H/10T1/2 mouse embryo fibroblasts by 3-methylcholanthrene. Proc Natl Acad Sci U S A. 1980 Dec;77(12):7272–7276. doi: 10.1073/pnas.77.12.7272. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Fisher E. F., Caruthers M. H. Studies on gene control regions XII. The functional significance of a lac operator constitutive mutation. Nucleic Acids Res. 1979 Sep 25;7(2):401–416. doi: 10.1093/nar/7.2.401. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Flatau E., Bogenmann E., Jones P. A. Variable 5-methylcytosine levels in human tumor cell lines and fresh pediatric tumor explants. Cancer Res. 1983 Oct;43(10):4901–4905. [PubMed] [Google Scholar]
- Gasson J. C., Ryden T., Bourgeois S. Role of de novo DNA methylation in the glucocorticoid resistance of a T-lymphoid cell line. Nature. 1983 Apr 14;302(5909):621–623. doi: 10.1038/302621a0. [DOI] [PubMed] [Google Scholar]
- Groffen J., Heisterkamp N., Blennerhassett G., Stephenson J. R. Regulation of viral and cellular oncogene expression by cytosine methylation. Virology. 1983 Apr 15;126(1):213–227. doi: 10.1016/0042-6822(83)90473-7. [DOI] [PubMed] [Google Scholar]
- Groudine M., Eisenman R., Weintraub H. Chromatin structure of endogenous retroviral genes and activation by an inhibitor of DNA methylation. Nature. 1981 Jul 23;292(5821):311–317. doi: 10.1038/292311a0. [DOI] [PubMed] [Google Scholar]
- Halle S. 5-Azacytidine as a mutagen for arboviruses. J Virol. 1968 Oct;2(10):1228–1229. doi: 10.1128/jvi.2.10.1228-1229.1968. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Harris M. Induction of thymidine kinase in enzyme-deficient Chinese hamster cells. Cell. 1982 Jun;29(2):483–492. doi: 10.1016/0092-8674(82)90165-9. [DOI] [PubMed] [Google Scholar]
- Harrison J. J., Anisowicz A., Gadi I. K., Raffeld M., Sager R. Azacytidine-induced tumorigenesis of CHEF/18 cells: correlated DNA methylation and chromosome changes. Proc Natl Acad Sci U S A. 1983 Nov;80(21):6606–6610. doi: 10.1073/pnas.80.21.6606. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Hollstein M., McCann J., Angelosanto F. A., Nichols W. W. Short-term tests for carcinogens and mutagens. Mutat Res. 1979 Sep;65(3):133–226. doi: 10.1016/0165-1110(79)90014-9. [DOI] [PubMed] [Google Scholar]
- Johnson M. H. X-chromosome inactivation and the control of gene expression. Nature. 1982 Apr 8;296(5857):493–494. doi: 10.1038/296493a0. [DOI] [PubMed] [Google Scholar]
- Jones P. A., Taylor S. M. Cellular differentiation, cytidine analogs and DNA methylation. Cell. 1980 May;20(1):85–93. doi: 10.1016/0092-8674(80)90237-8. [DOI] [PubMed] [Google Scholar]
- Kennedy A. R., Cairns J., Little J. B. Timing of the steps in transformation of C3H 10T 1/2 cells by X-irradiation. Nature. 1984 Jan 5;307(5946):85–86. doi: 10.1038/307085a0. [DOI] [PubMed] [Google Scholar]
- Knaap A. G., Glickman B. W., Simons J. W. Effects of ethionine on the replicational fidelity in V79 chinese hamster cells. Mutat Res. 1981 Jul;82(2):355–363. doi: 10.1016/0027-5107(81)90164-0. [DOI] [PubMed] [Google Scholar]
- Korba B. E., Hays J. B. Partially deficient methylation of cytosine in DNA at CCATGG sites stimulates genetic recombination of bacteriophage lambda. Cell. 1982 Mar;28(3):531–541. doi: 10.1016/0092-8674(82)90208-2. [DOI] [PubMed] [Google Scholar]
- Kuhlmann I., Doerfler W. Shifts in the extent and patterns of DNA methylation upon explanation and subcultivation of adenovirus type 12-induced hamster tumor cells. Virology. 1982 Apr 15;118(1):169–180. doi: 10.1016/0042-6822(82)90330-0. [DOI] [PubMed] [Google Scholar]
- Kuo K. C., McCune R. A., Gehrke C. W., Midgett R., Ehrlich M. Quantitative reversed-phase high performance liquid chromatographic determination of major and modified deoxyribonucleosides in DNA. Nucleic Acids Res. 1980 Oct 24;8(20):4763–4776. doi: 10.1093/nar/8.20.4763. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Land H., Parada L. F., Weinberg R. A. Cellular oncogenes and multistep carcinogenesis. Science. 1983 Nov 18;222(4625):771–778. doi: 10.1126/science.6356358. [DOI] [PubMed] [Google Scholar]
- Landolph J. R., Jones P. A. Mutagenicity of 5-azacytidine and related nucleosides in C3H/10T 1/2 clone 8 and V79 cells. Cancer Res. 1982 Mar;42(3):817–823. [PubMed] [Google Scholar]
- Leder P., Battey J., Lenoir G., Moulding C., Murphy W., Potter H., Stewart T., Taub R. Translocations among antibody genes in human cancer. Science. 1983 Nov 18;222(4625):765–771. doi: 10.1126/science.6356357. [DOI] [PubMed] [Google Scholar]
- Lester S. C., Korn N. J., DeMars R. Derepression of genes on the human inactive X chromosome: evidence for differences in locus-specific rates of derepression and rates of transfer of active and inactive genes after DNA-mediated transformation. Somatic Cell Genet. 1982 Mar;8(2):265–284. doi: 10.1007/BF01538681. [DOI] [PubMed] [Google Scholar]
- Marquardt H., Marquardt H. Induction of malignant transformation and mutagenesis in cell cultures by cancer chemotherapeutic agents. Cancer. 1977 Oct;40(4 Suppl):1930–1934. doi: 10.1002/1097-0142(197710)40:4+<1930::aid-cncr2820400826>3.0.co;2-8. [DOI] [PubMed] [Google Scholar]
- McCann J., Ames B. N. Detection of carcinogens as mutagens in the Salmonella/microsome test: assay of 300 chemicals: discussion. Proc Natl Acad Sci U S A. 1976 Mar;73(3):950–954. doi: 10.1073/pnas.73.3.950. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Mintz B., Fleischman R. A. Teratocarcinomas and other neoplasms as developmental defects in gene expression. Adv Cancer Res. 1981;34:211–278. doi: 10.1016/s0065-230x(08)60243-2. [DOI] [PubMed] [Google Scholar]
- Mohandas T., Sparkes R. S., Shapiro L. J. Reactivation of an inactive human X chromosome: evidence for X inactivation by DNA methylation. Science. 1981 Jan 23;211(4480):393–396. doi: 10.1126/science.6164095. [DOI] [PubMed] [Google Scholar]
- Nickol J., Behe M., Felsenfeld G. Effect of the B--Z transition in poly(dG-m5dC) . poly(dG-m5dC) on nucleosome formation. Proc Natl Acad Sci U S A. 1982 Mar;79(6):1771–1775. doi: 10.1073/pnas.79.6.1771. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Ossowski L., Reich E. Changes in malignant phenotype of a human carcinoma conditioned by growth environment. Cell. 1983 Jun;33(2):323–333. doi: 10.1016/0092-8674(83)90414-2. [DOI] [PubMed] [Google Scholar]
- Ostrander M., Vogel S., Silverstein S. Phenotypic switching in cells transformed with the herpes simplex virus thymidine kinase gene. Mol Cell Biol. 1982 Jun;2(6):708–714. doi: 10.1128/mcb.2.6.708. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Paul P. Mutagenesis and transformation of C3H/10T1/2 mouse embryo fibroblasts with ultraviolet light and 5-azacytidine. Kobe J Med Sci. 1982 Dec;28(5-6):181–196. [PubMed] [Google Scholar]
- Riggs A. D., Jones P. A. 5-methylcytosine, gene regulation, and cancer. Adv Cancer Res. 1983;40:1–30. doi: 10.1016/s0065-230x(08)60678-8. [DOI] [PubMed] [Google Scholar]
- Rowley J. D., Testa J. R. Chromosome abnormalities in malignant hematologic diseases. Adv Cancer Res. 1982;36:103–148. doi: 10.1016/s0065-230x(08)60423-6. [DOI] [PubMed] [Google Scholar]
- STOKER M., MACPHERSON I. SYRIAN HAMSTER FIBROBLAST CELL LINE BHK21 AND ITS DERIVATIVES. Nature. 1964 Sep 26;203:1355–1357. doi: 10.1038/2031355a0. [DOI] [PubMed] [Google Scholar]
- Sager R., Kovac P. Pre-adipocyte determination either by insulin or by 5-azacytidine. Proc Natl Acad Sci U S A. 1982 Jan;79(2):480–484. doi: 10.1073/pnas.79.2.480. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Santi D. V., Garrett C. E., Barr P. J. On the mechanism of inhibition of DNA-cytosine methyltransferases by cytosine analogs. Cell. 1983 May;33(1):9–10. doi: 10.1016/0092-8674(83)90327-6. [DOI] [PubMed] [Google Scholar]
- Saxholm H. J., Digernes V. Progressive loss of DNA and lowering of the chromosomal mode in chemically transformed C3H/10T1/2 cells during development of their oncogenic potential. Cancer Res. 1980 Nov;40(11):4254–4260. [PubMed] [Google Scholar]
- Shmookler Reis R. J., Goldstein S. Variability of DNA methylation patterns during serial passage of human diploid fibroblasts. Proc Natl Acad Sci U S A. 1982 Jul;79(13):3949–3953. doi: 10.1073/pnas.79.13.3949. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Siminovitch L. On the nature of hereditable variation in cultured somatic cells. Cell. 1976 Jan;7(1):1–11. doi: 10.1016/0092-8674(76)90249-x. [DOI] [PubMed] [Google Scholar]
- Smith B. L., Sager R. Multistep origin of tumor-forming ability in Chinese hamster embryo fibroblast cells. Cancer Res. 1982 Feb;42(2):389–396. [PubMed] [Google Scholar]
- Stoner G. D., Shimkin M. B., Kniazeff A. J., Weisburger J. H., Weisburger E. K., Gori G. B. Test for carcinogenicity of food additives and chemotherapeutic agents by the pulmonary tumor response in strain A mice. Cancer Res. 1973 Dec;33(12):3069–3085. [PubMed] [Google Scholar]
- Sugiyama R. H., Arfin S. M., Harris M. Properties of asparagine synthetase in asparagine-independent variants of Jensen rat sarcoma cells induced by 5-azacytidine. Mol Cell Biol. 1983 Nov;3(11):1937–1942. doi: 10.1128/mcb.3.11.1937. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Taylor S. M., Jones P. A. Multiple new phenotypes induced in 10T1/2 and 3T3 cells treated with 5-azacytidine. Cell. 1979 Aug;17(4):771–779. doi: 10.1016/0092-8674(79)90317-9. [DOI] [PubMed] [Google Scholar]
- Vardimon L., Günthert U., Doerfler W. In vitro methylation of the BsuRI (5'-GGCC-3') sites in the E2a region of adenovirus type 2 DNA does not affect expression in Xenopus laevis oocytes. Mol Cell Biol. 1982 Dec;2(12):1574–1580. doi: 10.1128/mcb.2.12.1574. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Wigler M., Levy D., Perucho M. The somatic replication of DNA methylation. Cell. 1981 Apr;24(1):33–40. doi: 10.1016/0092-8674(81)90498-0. [DOI] [PubMed] [Google Scholar]
- Wilson V. L., Jones P. A. Inhibition of DNA methylation by chemical carcinogens in vitro. Cell. 1983 Jan;32(1):239–246. doi: 10.1016/0092-8674(83)90514-7. [DOI] [PubMed] [Google Scholar]
- Wolf S. F., Migeon B. R. Studies of X chromosome DNA methylation in normal human cells. Nature. 1982 Feb 25;295(5851):667–671. doi: 10.1038/295667a0. [DOI] [PubMed] [Google Scholar]